
Sign up to save your podcasts
Or


Topical therapies are a mainstay of psoriasis care but can be challenging to use. Hear what challenges they present and how the latest topicals - Tapinarof and Roflumilast could revolutionize topical treatments from dermatologist and NPF Medical Board member, Dr. Larry Green, Aesthetics and Dermatology Center in Rockville, MD. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.
By National Psoriasis Foundation4.8
3838 ratings
Topical therapies are a mainstay of psoriasis care but can be challenging to use. Hear what challenges they present and how the latest topicals - Tapinarof and Roflumilast could revolutionize topical treatments from dermatologist and NPF Medical Board member, Dr. Larry Green, Aesthetics and Dermatology Center in Rockville, MD. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.

21,935 Listeners

43,819 Listeners

32,220 Listeners

30,643 Listeners

43,662 Listeners

9,750 Listeners

113,463 Listeners

56,997 Listeners

3,935 Listeners

165,422 Listeners

4,826 Listeners

6,446 Listeners

29,280 Listeners

31 Listeners

20,335 Listeners